Methicillin-resistant Staphylococcus aureus: An ever emerging threat

Therapy

Volumn 7, Issue 2, 2010, Pages 169-178

  Bertrand, X ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Community; Emergence epidemiology; Hospital; Infection control; Methicillin resistant; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; FUSIDIC ACID; KANAMYCIN; METICILLIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN DERIVATIVE; PENICILLINASE; PSEUDOMONIC ACID; TETRACYCLINE DERIVATIVE; TOXIC SHOCK SYNDROME TOXIN 1;

ANTIBIOTIC SENSITIVITY; BACTERIAL CHROMOSOME; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CONTAMINATION; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CATHETER INFECTION; COMMUNICABLE DISEASE; COMORBIDITY; DISEASE SURVEILLANCE; DISINFECTION; GREECE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; PERSONAL HYGIENE; PREVALENCE; RECURRENT INFECTION; REVIEW; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 77949573217     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/thy.10.1     Document Type: Review

References (70)

1. Kluytmans J, van Belkum A, Verbrugh H: Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10(3), 505-520 (1997).
2. Lowy FD: Staphylococcus aureus infections. N. Engl. J. Med. 339(8), 520-532 (1998).
3. Jevons MP, Coe AW, Parker MT: Methicillin resistance in staphylococci. Lancet 1(7287), 904-907 (1963).
4. Couto I, de Lencastre H, Severina E et al.: Ubiquitous presence of a mecA homologue in natural isolates of Staphylococcus sciuri. Microb. Drug Resist. 2(4), 377-391 (1996).
5. Boucher HW, Corey GR: Epidemiology of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 46(Suppl. 5), S344-S349 (2008).
6. Navarro MB, Huttner B, Harbarth S: Methicillin-resistant Staphylococcus aureus control in the 21st century: beyond the acute care hospital. Curr. Opin. Infect. Dis. 21(4), 372-379 (2008).
7. Ayliffe GA: The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 24(Suppl. 1), S74-S79 (1997).
8. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y: The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect. Control. Hosp. Epidemiol. 26(2), 166-174 (2005).
9. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E: Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368(9538), 874-885 (2006).
10. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39(3), 309-317 (2004).
11. Diekema DJ, Pfaller MA, Schmitz FJ et al.: Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2), S114-S132 (2001).
12. Garau J, Bouza E, Chastre J, Gudiol F, Harbarth S: Management of methicillin-resistant Staphylococcus aureus infections. Clin. Microbiol. Infect. 15(2), 125-136 (2009).
13. Deurenberg RH, Stobberingh EE: The evolution of Staphylococcus aureus. Infect. Genet. Evol. 8(6), 747-763 (2008).
14. Kreiswirth B, Kornblum J, Arbeit RD et al.: Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science 259(5092), 227-230 (1993).
15. Fitzgerald JR, Sturdevant DE, Mackie SM, Gill SR, Musser JM: Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc. Natl Acad. Sci. USA 98(15), 8821-8826 (2001).
16. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG: The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl Acad. Sci. USA 99(11), 7687-7692 (2002).
17. Aires-de-Sousa M, Correia B, de Lencastre H: Changing patterns in frequency of recovery of five methicillin-resistant Staphylococcus aureus clones in portuguese hospitals: surveillance over a 16-year period. J. Clin. Microbiol. 46(9), 2912-2917 (2008).
18. Aires-de-Sousa M, de Lencastre H: Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones. FEMS Immunol. Med. Microbiol. 40(2), 101-111 (2004).
19. Eveillard M, Charru P, Rufat P et al.: Methicillin-resistant Staphylococcus aureus carriage in a long-term care facility: hypothesis about selection and transmission. Age Ageing 37(3), 294-299 (2008).
20. Muto CA, Jernigan JA, Ostrowsky BE et al.: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect. Control. Hosp. Epidemiol. 24(5), 362-386 (2003).
21. Pittet D, Hugonnet S, Harbarth S et al.: Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 356(9238), 1307-1312 (2000).
22. Humphreys H, Grundmann H, Skov R, Lucet JC, Cauda R: Prevention and control of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 15(2), 120-124 (2009).
23. Cooper BS, Stone SP, Kibbler CC et al.: Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA), systematic review of the literature. BMJ 329(7465), 533 (2004).
24. Shardell M, Harris AD, El-Kamary SS, Furuno JP, Miller RR, Perencevich EN: Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin. Infect. Dis. 45(7), 901-907 (2007).
25. Vernaz N, Sax H, Pittet D, Bonnabry P, Schrenzel J, Harbarth S: Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J. Antimicrob. Chemother. 62(3), 601-607 (2008).
26. Harbarth S, Fankhauser C, Schrenzel J et al.: Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 299(10), 1149-1157 (2008).
27. Monnet DL, MacKenzie FM, Lopez- Lozano JM et al.: Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg. Infect. Dis. 10(8), 1432-1441 (2004).
28. Muller A, Mauny F, Talon D, Donnan PT, Harbarth S, Bertrand X: Effect of individual-and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. J. Antimicrob. Chemother. 58(4), 878-881 (2006).
29. Aldeyab MA, Monnet DL, Lopez-Lozano JM et al.: Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J. Antimicrob. Chemother. 62(3), 593-600 (2008).
30. Bisognano C, Vaudaux P, Rohner P, Lew DP, Hooper DC: Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother. 44(6), 1428-1437 (2000).
31. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R: Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J. Antimicrob. Chemother. 61(1), 26-38 (2008).
32. Ferech M, Andrasevic A, Coenen S, Francetic I, Goossens H: Outpatient use of systemic antibiotics in Croatia. Pharm. World Sci. 28(1), 39-40; author reply 1 (2006).
33. Goossens H, Ferech M, Vander Stichele R, Elseviers M: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365(9459), 579-587 (2005).
34. Udo EE, Pearman JW, Grubb WB: Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J. Hosp. Infect. 25(2), 97-108 (1993).
35. No authors listed. The Centers for Disease Control and Prevention: Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. JAMA 282(12), 1123-1125 (1999).
36. Gillet Y, Issartel B, Vanhems P et al.: Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359(9308), 753-759 (2002).
37. Robinson DA, Kearns AM, Holmes A et al.: Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 365(9466), 1256-1258 (2005).
38. Diep BA, Sensabaugh GF, Somboona NS, Carleton HA, Perdreau-Remington F: Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J. Clin. Microbiol. 42(5), 2080-2084 (2004).
39. Gbaguidi-Haore H, Thouverez M, Couetdic G, Cholley P, Talon D, Bertrand X: Usefulness of antimicrobial resistance pattern for detecting PVL- or TSST-1-producing MRSA in a French university hospital. J. Med. Microbiol. 58, 1337-1340 (2009).
40. Jappe U, Heuck D, Strommenger B et al.: Staphylococcus aureus in dermatology outpatients with special emphasis on community-associated methicillin-resistant strains. J. Invest. Dermatol. 128(11), 2655-2664 (2008).
41. Moran GJ, Krishnadasan A, Gorwitz RJ et al.: Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355(7), 666-674 (2006).
42. Tenover FC, Goering RV: Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J. Antimicrob. Chemother. 64(3), 441-446 (2009).
43. Popovich KJ, Weinstein RA, Hota B: Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin. Infect. Dis. 46(6), 787-794 (2008).
44. Diep BA, Chambers HF, Graber CJ et al.: Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann. Intern. Med. 148(4), 249-257 (2008).
45. Dauwalder O, Lina G, Durand G et al.: Epidemiology of invasive methicillin-resistant Staphylococcus aureus clones collected in France in 2006 and 2007. J. Clin. Microbiol. 46(10), 3454-3458 (2008).
46. Del Giudice P, Blanc V, Durupt F et al.: Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. Br. J. Dermatol. 154(1), 118-124 (2006).
47. Witte W, Strommenger B, Cuny C, Heuck D, Nuebel U: Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. J. Antimicrob. Chemother. 60(6), 1258-1263 (2007).
48. Chini V, Petinaki E, Foka A, Paratiras S, Dimitracopoulos G, Spiliopoulou I: Spread of Staphylococcus aureus clinical isolates carrying Panton-Valentine leukocidin genes during a 3-year period in Greece. Clin. Microbiol. Infect. 12(1), 29-34 (2006).
49. Ramdani-Bouguessa N, Bes M, Meugnier H et al.: Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital. Antimicrob. Agents Chemother. 50(3), 1083-1085 (2006).
50. Wang R, Braughton KR, Kretschmer D et al.: Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13(12), 1510-1514 (2007).
51. Diep BA, Stone GG, Basuino L et al.: The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 197(11), 1523-1530 (2008).
52. Dumitrescu O, Tristan A, Meugnier H et al.: Polymorphism of the Staphylococcus aureus Panton-Valentine leukocidin genes and its possible link with the fitness of community-associated methicillin-resistant S. aureus. J. Infect. Dis. 198(5), 792-794 (2008).
53. van der Mee-Marquet N, Lina G, Quentin R et al.: Staphylococcal exanthematous disease in a newborn due to a virulent methicillin-resistant Staphylococcus aureus strain containing the TSST-1 gene in Europe: an alert for neonatologists. J. Clin. Microbiol. 41(10), 4883-4884 (2003).
54. Durand G, Bes M, Meugnier H et al.: Detection of new methicillin- resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital and community-acquired infections in France. J. Clin. Microbiol. 44(3), 847-853 (2006).
55. Todd J, Fishaut M, Kapral F, Welch T: Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet 2(8100), 1116-1118 (1978).
56. Kikuchi K, Takahashi N, Piao C, Totsuka K, Nishida H, Uchiyama T: Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. J. Clin. Microbiol. 41(7), 3001-3006 (2003).
57. Lewis HC, Molbak K, Reese C et al.: Pigs as source of methicillin-resistant Staphylococcus aureus CC398 infections in humans, Denmark. Emerg. Infect. Dis. 14(9), 1383-1389 (2008).
58. Vitale CB, Gross TL, Weese JS: Methicillin-resistant Staphylococcus aureus in cat and owner. Emerg. Infect. Dis. 12(12), 1998-2000 (2006).
59. van Loo I, Huijsdens X, Tiemersma E et al.: Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg. Infect. Dis. 13(12), 1834-1839 (2007).
60. Morgan M: Methicillin-resistant Staphylococcus aureus and animals: zoonosis or humanosis? J. Antimicrob. Chemother. 62(6), 1181-1187 (2008).
61. van Loo IH, Diederen BM, Savelkoul PH et al.: Methicillin-resistant Staphylococcus aureus in meat products, The Netherlands. Emerg. Infect. Dis. 13(11), 1753-1755 (2007).
62. Denis O, Suetens C, Hallin M et al.: Methicillin-resistant Staphylococcus aureus ST398 in swine farm personnel, Belgium. Emerg. Infect. Dis. 15(7), 1098-1101 (2009).
63. Pan A, Battisti A, Zoncada A et al.: Community-acquired methicillin-resistant Staphylococcus aureus ST398 infection, Italy. Emerg. Infect. Dis. 15(5), 845-847 (2009).
64. Krziwanek K, Metz-Gercek S, Mittermayer H: Methicillin-resistant Staphylococcus aureus ST398 from human patients, upper Austria. Emerg. Infect. Dis. 15(5), 766-769 (2009).
65. Hanselman BA, Kruth SA, Rousseau J et al.: Methicillin-resistant Staphylococcus aureus colonization in veterinary personnel. Emerg. Infect. Dis. 12(12), 1933-1938 (2006).
66. Wulf MW, Sorum M, van Nes A et al.: Prevalence of methicillin-resistant Staphylococcus aureus among veterinarians: an international study. Clin. Microbiol. Infect. 14(1), 29-34 (2008).
67. van Rijen MM, Van Keulen PH, Kluytmans JA: Increase in a Dutch hospital of methicillin-resistant Staphylococcus aureus related to animal farming. Clin. Infect. Dis. 46(2), 261-263 (2008).
68. Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT: Epidemiology of Staphylococcus aureus bacteremia in Denmark from to 1990. Clin. Microbiol. Infect. 1997 3(3), 297-305 (1957).
69. Bartels MD, Kristoffersen K, Boye K, Westh H: Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search and destroy policy. Clin. Microbiol. Infect. May 16 (2009).
70. Chambers HF, Deleo FR: Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7(9), 629-641 (2009).